NOVYX · Next-Generation Metabolics
Retatrutide - Triple Receptor Agonist Peptide
Triple-agonist precision for next-generation metabolic research.
A 30 mg lyophilized research peptide designed for controlled laboratory studies of GIP, GLP-1, and glucagon receptor co-activation and metabolic signaling pathways. High-purity formulation for reproducible in vitro research applications.
Pack: 1 × Retatrutide 30 mg research vial
Technical profile
Product reference
retatrutide
Product group
Peptide
Category
Metabolic
Vial size
30 mg
Purity
99.5%
Form
Lyophilized Powder
Molecular weight
—
Molecular formula
—
Availability
In stock
Featured
Research presentation only. Product handling and laboratory use should follow the supplied technical documentation.
Yes
Published
Yes
Sequence
Research specification available on request
Storage
Store lyophilized vial at -20°C, protected from light and moisture. Avoid repeated freeze-thaw cycles. Refer to laboratory stability protocols for long-term storage.
Handling
For research use only. Reconstitute aseptically with sterile bacteriostatic water under controlled laboratory conditions. Swirl gently until dissolved; do not vortex. Not for human or veterinary use.
